Physician profile
Jeffrey E Lee
NPI 1801943279
$3,246.75
in general payments reported to CMS, 2019-2025
12 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $60.50 · 2021: $233 · 2022: $152 · 2023: $156 · 2024: $1,958 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Food and Beverage | $800.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,556.75 | 2019-2025 | Hydrus Microstent, Clareon, Centurion |
| Amgen INC. | $175.78 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $122.47 | 2023-2024 | Envista Mx60 Iol, Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $98.10 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $86.25 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro Bypass System |
| Horizon Therapeutics Plc | $50.95 | 2021 | |
| Sun Pharmaceutical Industries INC. | $34.55 | 2025 | |
| Dompe US, INC. | $33.06 | 2025 | Oxervate |
| Abbvie INC. | $30.92 | 2023 | |
| Kedrion Biopharma, INC. | $23.43 | 2025 | Gammaked, Kedrab, Koate |
| Novartis Pharmaceuticals Corporation | $18.62 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.